Literature DB >> 19058762

IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice.

Colin Edgerton1, José C Crispín, Chantal M Moratz, Estelle Bettelli, Mohamed Oukka, Milomir Simovic, Athina Zacharia, Ryan Egan, Jie Chen, Jurandir J Dalle Lucca, Yuang-Taung Juang, George C Tsokos.   

Abstract

Elements of the innate and adaptive immune response have been implicated in the development of tissue damage after ischemic reperfusion (I/R). Here we demonstrate that T cells infiltrate the intestine of C57BL/6 mice subjected to intestinal I/R during the first hour of reperfusion. The intensity of the T cell infiltration was higher in B6.MRL/lpr mice subjected to intestinal I/R and reflected more severe tissue damage than that observed in control mice. Depletion of T cells limited I/R damage in B6.MRL/lpr mice, whereas repletion of B6.MRL/lpr lymph node-derived T cells into the I/R-resistant Rag-1(-/-) mouse reconstituted tissue injury. The tissue-infiltrating T cells were found to produce IL-17. Finally, IL-23 deficient mice, which are known not to produce IL-17, displayed significantly less intestinal damage when subjected to I/R. Our data assign T cells a major role in intestinal I/R damage by virtue of producing the pro-inflammatory cytokine IL-17.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19058762      PMCID: PMC2661238          DOI: 10.1016/j.clim.2008.09.019

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  40 in total

1.  Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.

Authors:  Emily Somers; Laurence S Magder; Michelle Petri
Journal:  J Rheumatol       Date:  2002-12       Impact factor: 4.666

2.  Accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice.

Authors:  Sherry D Fleming; Marc Monestier; George C Tsokos
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

3.  T cells and in situ cryoglobulin deposition in the pathogenesis of lupus nephritis.

Authors:  Robert A Cohen; George Bayliss; Jose C Crispin; Gwen F Kane-Wanger; Christine A Van Beek; Vasileios C Kyttaris; Ingrid Avalos; C Yung Yu; George C Tsokos; Isaac E Stillman
Journal:  Clin Immunol       Date:  2008-07       Impact factor: 3.969

4.  Cold liver ischemia-reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice.

Authors:  O Le Moine; H Louis; A Demols; F Desalle; F Demoor; E Quertinmont; M Goldman; J Devière
Journal:  Hepatology       Date:  2000-06       Impact factor: 17.425

5.  Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.

Authors:  Sudeepta Aggarwal; Nico Ghilardi; Ming-Hong Xie; Frederic J de Sauvage; Austin L Gurney
Journal:  J Biol Chem       Date:  2002-11-03       Impact factor: 5.157

6.  Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice.

Authors:  S Rehrig; S D Fleming; J Anderson; J M Guthridge; J Rakstang; C E McQueen; V M Holers; G C Tsokos; T Shea-Donohue
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

7.  T-lymphocytes modulate the microvascular and inflammatory responses to intestinal ischemia-reperfusion.

Authors:  Takeharu Shigematsu; Robert E Wolf; D Neil Granger
Journal:  Microcirculation       Date:  2002-04       Impact factor: 2.628

8.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.

Authors:  Daniel J Cua; Jonathan Sherlock; Yi Chen; Craig A Murphy; Barbara Joyce; Brian Seymour; Linda Lucian; Wayne To; Sylvia Kwan; Tatyana Churakova; Sandra Zurawski; Maria Wiekowski; Sergio A Lira; Daniel Gorman; Robert A Kastelein; Jonathon D Sedgwick
Journal:  Nature       Date:  2003-02-13       Impact factor: 49.962

9.  Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice.

Authors:  Nico Ghilardi; Noelyn Kljavin; Qi Chen; Sophie Lucas; Austin L Gurney; Frederic J De Sauvage
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

10.  Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice.

Authors:  Susumu Nakae; Aya Nambu; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

View more
  39 in total

Review 1.  Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.

Authors:  Jamie R Flammer; Inez Rogatsky
Journal:  Mol Endocrinol       Date:  2011-04-21

2.  Atorvastatin reduces tissue damage in rat ovaries subjected to torsion and detorsion: biochemical and histopathologic evaluation.

Authors:  Elif Cadirci; Akgun Oral; Fehmi Odabasoglu; Cenk Kilic; Kagan Coskun; Zekai Halici; Halis Suleyman; Osman Nuri Keles; Bunyami Unal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-27       Impact factor: 3.000

3.  Spleen tyrosine kinase inhibition prevents tissue damage after ischemia-reperfusion.

Authors:  Omer Nuri Pamuk; Peter H Lapchak; Poonam Rani; Polly Pine; Jurandir J Dalle Lucca; George C Tsokos
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-03       Impact factor: 4.052

4.  Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration.

Authors:  Yu-Hua Liao; Ni Xia; Su-Feng Zhou; Ting-Ting Tang; Xin-Xin Yan; Bing-Jie Lv; Shao-Fang Nie; Jing Wang; Yoichiro Iwakura; Hong Xiao; Jing Yuan; Harish Jevallee; Fen Wei; Guo-Ping Shi; Xiang Cheng
Journal:  J Am Coll Cardiol       Date:  2012-01-24       Impact factor: 24.094

5.  Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus.

Authors:  Eneida Villanueva; Srilakshmi Yalavarthi; Celine C Berthier; Jeffrey B Hodgin; Ritika Khandpur; Andrew M Lin; Cory J Rubin; Wenpu Zhao; Stephen H Olsen; Matthew Klinker; David Shealy; Michael F Denny; Joel Plumas; Laurence Chaperot; Matthias Kretzler; Allen T Bruce; Mariana J Kaplan
Journal:  J Immunol       Date:  2011-05-25       Impact factor: 5.422

Review 6.  Mesenchymal stromal cell therapy for the treatment of intestinal ischemia: Defining the optimal cell isolate for maximum therapeutic benefit.

Authors:  Dominique L Doster; Amanda R Jensen; Sina Khaneki; Troy A Markel
Journal:  Cytotherapy       Date:  2016-10-10       Impact factor: 5.414

7.  Macrophage-produced IL-12p70 mediates hemorrhage-induced damage in a complement-dependent manner.

Authors:  Diana J Hylton; Sara M Hoffman; N Van Rooijen; Stephen Tomlinson; Sherry D Fleming
Journal:  Shock       Date:  2011-02       Impact factor: 3.454

Review 8.  Interleukin-17 and systemic lupus erythematosus: current concepts.

Authors:  A Nalbandian; J C Crispín; G C Tsokos
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 9.  Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances.

Authors:  Desmond Yat Hin Yap; Kar Neng Lai
Journal:  J Biomed Biotechnol       Date:  2010-05-06

10.  Heightened Immune Activation in Fetuses with Gastroschisis May Be Blocked by Targeting IL-5.

Authors:  Michela Frascoli; Cerine Jeanty; Shannon Fleck; Patriss W Moradi; Sheila Keating; Aras N Mattis; Qizhi Tang; Tippi C MacKenzie
Journal:  J Immunol       Date:  2016-05-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.